COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #11 of 63
9/15 Review
Jans et al., Cells 2020, 9:9, 2100, doi:10.3390/cells9092100 (Review) (Letter)
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Source   PDF   Share   Tweet
Review of ivermectin as a host-directed broad-spectrum antiviral agent for a range of viruses, including SARS-CoV-2.
Cell culture experiments show robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-CoV-2 (COVID-19).

Jans et al., 9/15/2020, preprint, 2 authors.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit